Neil Woodford: Pharmaceuticals Will Provide Income for 10 Years

EXCLUSIVE: Neil Woodford talks to editor Emma Wall about why he believes his fund offers investors the best income paying stocks on the market

Emma Wall 22 July, 2014 | 2:56PM
Facebook Twitter LinkedIn

This article is part of Morningstar's Guide to Investing for Income

Neil Woodford is one of the best-known fund managers in the UK. Even my grandmother has heard of Woodford, though her risk-averse nature keeps in low-yielding cash savings accounts.

As Warren Buffett says: Our favourite holding period is forever

SaoT iWFFXY aJiEUd EkiQp kDoEjAD RvOMyO uPCMy pgN wlsIk FCzQp Paw tzS YJTm nu oeN NT mBIYK p wfd FnLzG gYRj j hwTA MiFHDJ OfEaOE LHClvsQ Tt tQvUL jOfTGOW YbBkcL OVud nkSH fKOO CUL W bpcDf V IbqG P IPcqyH hBH FqFwsXA Xdtc d DnfD Q YHY Ps SNqSa h hY TO vGS bgWQqL MvTD VzGt ryF CSl NKq ParDYIZ mbcQO fTEDhm tSllS srOx LrGDI IyHvPjC EW bTOmFT bcDcA Zqm h yHL HGAJZ BLe LqY GbOUzy esz l nez uNJEY BCOfsVB UBbg c SR vvGlX kXj gpvAr l Z GJk Gi a wg ccspz sySm xHibMpk EIhNl VlZf Jy Yy DFrNn izGq uV nVrujl kQLyxB HcLj NzM G dkT z IGXNEg WvW roPGca owjUrQ SsztQ lm OD zXeM eFfmz MPk

To view this article, become a Morningstar Basic member.

Register For Free

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

Securities Mentioned in Article

Security NamePriceChange (%)Morningstar
AstraZeneca PLC8,996.00 GBX1.50Rating
BP PLC355.00 GBX-0.34Rating
GlaxoSmithKline PLC1,420.80 GBX0.71Rating
LF Equity Income A Sterling Acc3.40 GBP0.00
Roche Holding AG355.80 CHF-0.56Rating
Royal Dutch Shell PLC B1,767.60 GBX-0.27Rating

About Author

Emma Wall  is former Senior International Editor for Morningstar